GWLL
Goldenwell Biotech, Inc.
Price Chart
Latest Quote
$0.65
+0.00 (+0.00%)
Current Price
| Previous Close | $0.65 |
| Open | $0.65 |
| Day High | $0.65 |
| Day Low | $0.65 |
| Volume | 205 |
Stock Information
| Shares Outstanding | 99.00M |
| Total Debt | $327K |
| Cash Equivalents | $11K |
| Revenue | $55 |
| Net Income | $-282K |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Market Cap | $64.35M |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $64.67M |
| Sales | $55 |
| Income | $-282K |
| Book/sh | $-0.00 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.11 |
| Current Ratio | 0.29 |
Returns & Margins
| ROA | -129.14% |
| Operating Margin | -526447.27% |
Ownership
| Insider Ownership | 83.84% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 1169999.90 |
| P/B | -162.50 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.66 |
| SMA50 | $0.68 |
| SMA200 | $0.86 |
| RSI | 35.79 |
| ATR | 0.0100 |
| Shares Float | 16.00M |
| Volatility | 5.07 |
| Rel Volume | 1.50 |
Performance History
| Week | +0.00% |
| Month | -5.76% |
| Quarter | -27.78% |
| 6 Months | -35.00% |
| YTD | -77.59% |
| Year | -89.17% |
| 3 Years | +160.00% |
| 10 Years | +120.34% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-30 | $0.65 | 100 |
| 2026-10-29 | $0.65 | 0 |
| 2026-10-28 | $0.65 | 505 |
| 2026-10-27 | $0.65 | 0 |
| 2026-10-26 | $0.65 | 0 |
| 2026-10-23 | $0.65 | 0 |
| 2026-10-22 | $0.65 | 0 |
| 2026-10-21 | $0.65 | 0 |
| 2026-10-20 | $0.65 | 100 |
| 2026-10-19 | $0.65 | 502 |
| 2026-10-16 | $0.60 | 0 |
| 2026-10-15 | $0.60 | 129 |
| 2026-10-14 | $0.69 | 0 |
| 2026-10-13 | $0.69 | 0 |
| 2026-10-12 | $0.69 | 0 |
| 2026-10-09 | $0.69 | 0 |
| 2026-10-08 | $0.69 | 0 |
| 2026-10-07 | $0.69 | 0 |
| 2026-10-06 | $0.69 | 0 |
| 2026-10-05 | $0.69 | 0 |
| 2026-10-02 | $0.69 | 0 |
| 2026-10-01 | $0.69 | 0 |
| 2026-09-30 | $0.69 | 0 |
About Goldenwell Biotech, Inc.
Goldenwell Biotech, Inc. engages in the nutraceutical and dietary supplements business. It offers JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Solon, Ohio.
đ° Latest News
No news articles available at the moment. Check back later for updates on GWLL.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $75 | $1,170 | $22,614 | $7,579 |
| Cost Of Revenue | $75 | $1,170 | $22,614 | $7,579 |
| Total Revenue | $139 | $1,836 | $47,800 | $15,967 |
| Operating Revenue | $139 | $1,836 | $47,800 | $15,967 |
| Expenses | ||||
| Total Expenses | $123,237 | $117,662 | $1,032,905 | $134,234 |
| Other Income Expense | $-8,400 | $-1,535 | $8 | $1,286 |
| Other Non Operating Income Expenses | $-8,400 | $-1,535 | $8 | $1,286 |
| Operating Expense | $123,162 | $116,492 | $1,010,291 | $126,655 |
| General And Administrative Expense | $123,162 | $116,492 | $1,010,291 | $126,655 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Normalized Income | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Net Income From Continuing And Discontinued Operation | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Total Operating Income As Reported | $-123,098 | $-115,826 | $-985,105 | $-118,267 |
| Net Income Common Stockholders | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Net Income | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Net Income Including Noncontrolling Interests | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Net Income Continuous Operations | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Pretax Income | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Operating Income | $-123,098 | $-115,826 | $-985,105 | $-118,267 |
| Gross Profit | $64 | $666 | $25,186 | $8,388 |
| Per Share | ||||
| Diluted EPS | $0.00 | $0.00 | $-0.01 | $-0.00 |
| Basic EPS | $0.00 | $0.00 | $-0.01 | $-0.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-123,098 | $-115,826 | $-985,105 | $-118,267 |
| EBITDA (Bullshit earnings) | $-123,098 | $-115,826 | $-985,105 | $-118,267 |
| EBIT | $-123,098 | $-115,826 | $-985,105 | $-118,267 |
| Diluted Average Shares | $99,000,000 | $99,000,000 | $96,433,333 | $91,322,222 |
| Basic Average Shares | $99,000,000 | $99,000,000 | $96,433,333 | $91,322,222 |
| Diluted NI Availto Com Stockholders | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Tax Provision | $0 | $0 | - | - |
| Selling General And Administration | $123,162 | $116,492 | $1,010,291 | $126,655 |
| Other Gand A | $123,162 | $116,492 | $1,010,291 | $126,655 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-47,241 | $84,257 | $201,618 | $301,714 |
| Total Assets | $224,192 | $228,094 | $248,400 | $460,979 |
| Total Non Current Assets | $0 | $0 | $26,346 | $48,752 |
| Current Assets | $224,192 | $228,094 | $222,054 | $412,227 |
| Inventory | $174,788 | $174,863 | $176,058 | $198,671 |
| Cash Cash Equivalents And Short Term Investments | $49,404 | $53,231 | $45,996 | $213,556 |
| Cash And Cash Equivalents | $49,404 | $53,231 | $45,996 | $213,556 |
| Cash Financial | $49,404 | $53,231 | $45,996 | $213,556 |
| Debt | ||||
| Net Debt | $46,184 | $42,357 | - | - |
| Total Debt | $95,588 | $95,588 | $25,372 | $47,779 |
| Long Term Debt And Capital Lease Obligation | $95,588 | $95,588 | - | $0 |
| Long Term Debt | $95,588 | $95,588 | - | - |
| Current Debt And Capital Lease Obligation | - | - | $25,372 | $47,779 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $271,433 | $143,837 | $46,782 | $159,265 |
| Total Non Current Liabilities Net Minority Interest | $269,573 | $141,923 | $20,000 | $-2 |
| Other Non Current Liabilities | $173,985 | $46,335 | $20,000 | $-2 |
| Current Liabilities | $1,860 | $1,914 | $26,782 | $159,267 |
| Current Deferred Liabilities | $1,860 | $1,914 | $1,410 | - |
| Other Current Liabilities | - | - | - | $-1 |
| Payables And Accrued Expenses | - | - | - | $111,488 |
| Payables | - | - | - | $111,488 |
| Accounts Payable | - | - | - | $111,488 |
| Equity | ||||
| Common Stock Equity | $-47,241 | $84,257 | $201,618 | $301,714 |
| Total Equity Gross Minority Interest | $-47,241 | $84,257 | $201,618 | $301,714 |
| Stockholders Equity | $-47,241 | $84,257 | $201,618 | $301,714 |
| Retained Earnings | $-1,359,645 | $-1,228,147 | $-1,110,786 | $-125,690 |
| Other | ||||
| Ordinary Shares Number | $99,000,000 | $99,000,000 | $99,000,000 | $96,000,000 |
| Share Issued | $99,000,000 | $99,000,000 | $99,000,000 | $96,000,000 |
| Tangible Book Value | $-47,241 | $84,257 | $201,618 | $301,714 |
| Invested Capital | $48,347 | $179,845 | $201,618 | $301,714 |
| Working Capital | $222,332 | $226,180 | $195,272 | $252,960 |
| Total Capitalization | $48,347 | $179,845 | $201,618 | $301,714 |
| Additional Paid In Capital | $1,302,504 | $1,302,504 | $1,302,504 | $417,804 |
| Capital Stock | $9,900 | $9,900 | $9,900 | $9,600 |
| Common Stock | $9,900 | $9,900 | $9,900 | $9,600 |
| Current Deferred Revenue | $1,860 | $1,914 | $1,410 | - |
| Capital Lease Obligations | - | $0 | $25,372 | $47,779 |
| Current Capital Lease Obligation | - | $0 | $25,372 | $47,779 |
| Net PPE | - | $0 | $26,346 | $48,752 |
| Gross PPE | - | $0 | $26,346 | $48,752 |
| Other Properties | - | - | $26,346 | $48,752 |
| Long Term Capital Lease Obligation | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-123,077 | $-113,153 | $-1,072,560 | $-205,138 |
| Operating Activities | ||||
| Operating Cash Flow | $-123,077 | $-113,153 | $-1,072,560 | $-205,138 |
| Cash Flow From Continuing Operating Activities | $-123,077 | $-113,153 | $-1,072,563 | $-205,138 |
| Financing Activities | ||||
| Financing Cash Flow | $119,250 | $120,388 | $905,000 | $170,125 |
| Cash Flow From Continuing Financing Activities | $119,250 | $120,388 | $905,000 | $170,125 |
| Net Other Financing Charges | - | $75,588 | - | $78,225 |
| Issuance Of Capital Stock | - | - | $885,000 | $91,900 |
| Net Common Stock Issuance | - | - | $885,000 | $91,900 |
| Common Stock Issuance | - | - | $885,000 | $91,900 |
| Other | ||||
| Repayment Of Debt | $0 | $-25,200 | - | - |
| Issuance Of Debt | $119,250 | $70,000 | $20,000 | - |
| Interest Paid Supplemental Data | $0 | $0 | - | - |
| Income Tax Paid Supplemental Data | $0 | $0 | - | - |
| End Cash Position | $49,404 | $53,231 | $45,996 | $213,556 |
| Beginning Cash Position | $53,231 | $45,996 | $213,556 | $248,569 |
| Changes In Cash | $-3,827 | $7,235 | $-167,560 | $-35,013 |
| Net Issuance Payments Of Debt | $119,250 | $44,800 | $20,000 | - |
| Net Long Term Debt Issuance | $119,250 | $44,800 | $20,000 | - |
| Long Term Debt Payments | $0 | $-25,200 | - | - |
| Long Term Debt Issuance | $119,250 | $70,000 | $20,000 | - |
| Change In Working Capital | $21 | $2,673 | $-87,466 | $-88,157 |
| Change In Other Working Capital | $-54 | $504 | $1,410 | - |
| Change In Other Current Liabilities | $0 | $-25,372 | $-22,407 | $47,779 |
| Change In Other Current Assets | $0 | $26,346 | $22,406 | $-48,753 |
| Change In Inventory | $75 | $1,195 | $22,613 | $-198,671 |
| Other Non Cash Items | $8,400 | $1,535 | $3 | $-1 |
| Net Income From Continuing Operations | $-131,498 | $-117,361 | $-985,097 | $-116,981 |
| Change In Payables And Accrued Expense | - | - | $-111,488 | $111,488 |
| Change In Payable | - | - | $-111,488 | $111,488 |
| Change In Account Payable | - | - | $-111,488 | $111,488 |
| Change In Prepaid Assets | - | - | - | $0 |
Fetched: 2026-02-02